SUBSCRIBE
SUBSCRIBE
News   Policy

FDA Concluded an Inspection of Apicore LLC’s API Manufacturing Plant in Somerset, NJ, USA with No Form 483 Citations

July 16, 2010 | 
1 min read
SOMERSET, N.J.--(BUSINESS WIRE)--Apicore LLC announced today that the U.S. Food and Drug Administration (FDA) completed an inspection of its API manufacturing plant in Somerset, New Jersey on July 13, 2010.
Regulatory
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
screenshot of Marty Makary speaking on the Megyn Kelly Show
Regulatory
Makary Doubles Down on Push To ‘Modernize’ FDA, Eyes Speedier Reviews
June 18, 2025
 · 
2 min read
 · 
Tristan Manalac
External view of the U.S. Capitol building
Drug pricing
Senate Republicans Drop Orphan Drug Exemptions From ‘One Big Beautiful Bill’
June 18, 2025
 · 
2 min read
 · 
Tristan Manalac
Podcast
Another Gene Therapy Death; Biopharma M&A Picks Up; a Vaccine Board of Vaccine Skeptics
June 18, 2025
 · 
1 min read
 · 
Heather McKenzie
Bureaucracy and administration management success with a group of tangled red tape and people running away on a pencil drawing line as a bureaucratic solution symbol with 3D illustration elements.
FDA
FDA Rolls Out Commissioner’s Priority Voucher Program to Speed Drug Reviews
June 17, 2025
 · 
2 min read
 · 
Annalee Armstrong